Finance

Beta
Lists
SDZXF:OTCMKTS
Sandoz Group AG
89,55 US$
0,00%
(0,00) 1D
91,75 US$
+2,46% (+2,20)
Pre-market
Closed: 25 ივნ, 09:30:12 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SDZXF...
Mkt. cap
31,89 მლრდ.
Avg. vol.
46,00
Volume
1,50 ათ.
52-wk high
94,55 US$
52-wk low
55,50 US$
Shares outstanding
440,00 მლნ.
No. of employees
22 ათ.
Mkt. cap
31,89 მლრდ.
Avg. vol.
46,00
Volume
1,50 ათ.
52-wk high
94,55 US$
52-wk low
55,50 US$
Shares outstanding
440,00 მლნ.
No. of employees
22 ათ.
News stories
From sources across the web
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About Sandoz Group AG
CEOრიჩარდ სეინორ
Employees22,4 ათ.
Founded1886
Headquarters-
SectorPharmaceutical industry
Websitesandoz.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
2,63 მლრდ.
2,63 მლრდ.
2,95 მლრდ.
2,95 მლრდ.
Cost of goods sold
1,43 მლრდ.
1,43 მლრდ.
1,50 მლრდ.
1,50 მლრდ.
Cost of revenue
1,43 მლრდ.
1,43 მლრდ.
1,50 მლრდ.
1,50 მლრდ.
Research and development expenses
252,00 მლნ.
252,00 მლნ.
272,00 მლნ.
272,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
596,00 მლნ.
596,00 მლნ.
668,50 მლნ.
668,50 მლნ.
Operating expense
904,50 მლნ.
904,50 მლნ.
1,02 მლრდ.
1,02 მლრდ.
Total operating expenses
2,33 მლრდ.
2,33 მლრდ.
2,52 მლრდ.
2,52 მლრდ.
Operating income
301,00 მლნ.
301,00 მლნ.
421,50 მლნ.
421,50 მლნ.
Other non operating income
6,50 მლნ.
6,50 მლნ.
-28,00 მლნ.
-28,00 მლნ.
EBT including unusual items
252,00 მლნ.
252,00 მლნ.
351,50 მლნ.
351,50 მლნ.
EBT excluding unusual items
252,00 მლნ.
252,00 მლნ.
367,50 მლნ.
367,50 მლნ.
Income tax expense
63,50 მლნ.
63,50 მლნ.
83,00 მლნ.
83,00 მლნ.
Effective tax rate
25,20%
25,20%
23,61%
23,61%
Other operating expenses
56,50 მლნ.
56,50 მლნ.
82,50 მლნ.
82,50 მლნ.
Net income
188,50 მლნ.
188,50 მლნ.
268,50 მლნ.
268,50 მლნ.
Net profit margin
7,16%
7,16%
9,11%
9,11%
Earnings per share
-
-
-
-
Interest and investment income
-
-
23,50 მლნ.
23,50 მლნ.
Interest expense
-55,50 მლნ.
-55,50 მლნ.
-54,50 მლნ.
-54,50 მლნ.
Net interest expenses
-55,50 მლნ.
-55,50 მლნ.
-31,00 მლნ.
-31,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
415,00 მლნ.
415,00 მლნ.
531,00 მლნ.
531,00 მლნ.
Gain or loss from assets sale
-8,00 მლნ.
-8,00 მლნ.
-3,00 მლნ.
-3,00 მლნ.
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more